Owners, management and financials
CVR: 37230634
Secondary names: Cmbio A/S
EUR 2,831,000
Gross profit
Net result: EUR -2,586,000
MANJIN ApS (5-9,99%), VENDLER ApS (5-9,99%)
3 more
CVR · view owners
Anders Christian Neto de Sousa Grøn
Board: Manoj Nirmal Dadlani (chair) and 5 members
CVR · view management
Active
Founded 2 November 2015
CVR · view overview
18 employees
CVR · 2018
Owner registered: Health For Life Capital II Prima S.C.A. RAIF
CVR · 01/07/2024
View the full event history
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 18 employees (2018). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.
Source: annual report 2025, Danish Business Authority
The financial health of Clinical-Microbiomics A/S shows a concerning trend, characterized by consistent losses over the past few years. In 2025, the company reported a gross profit of €2.83 million but incurred a loss of €2.59 million, following a pattern of declining profitability with losses increasing from €1.72 million in 2021 to €4.33 million in 2024. Despite these challenges, the company maintains a strong equity position of €85.45 million, indicating a solid financial foundation to support ongoing research and development efforts. However, the lack of disclosed revenue raises concerns about its market position and ability to generate sustainable income within the competitive landscape of scientific research and development.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at drive kontraktsforskning inden for bioteknologi samt hermed beslægtede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 2.8 mio. EUR | -2.6 mio. EUR | 92 mio. EUR | 85.4 mio. EUR | 115 | |
| 202401/01/2024 – 31/12/2024 | 548 t. EUR | -4.3 mio. EUR | 91.7 mio. EUR | 88 mio. EUR | 106 | |
| 202301/01/2023 – 31/12/2023 | 1.8 mio. EUR | -2 mio. EUR | 90.2 mio. EUR | 86.3 mio. EUR | 82 | |
| 202201/01/2022 – 31/12/2022 | 19 mio. | -6.9 mio. | 141.6 mio. | 119.5 mio. | 32 | |
| 202101/01/2021 – 31/12/2021 | 16.8 mio. | -1.7 mio. | 28.3 mio. | 2.8 mio. | 26 | |
| 202001/01/2020 – 31/12/2020 | 17 mio. | 816 t. | 12.5 mio. | -3.3 mio. | 19 | |
| 201901/01/2019 – 31/12/2019 | 13.2 mio. | 107 t. | 11.5 mio. | -4.1 mio. | 16 | |
| 201801/01/2018 – 31/12/2018 | 8.5 mio. | -483 t. | 6.3 mio. | -4.3 mio. | 12 | |
| 201701/01/2017 – 31/12/2017 | 1.4 mio. | -4.4 mio. | 3.7 mio. | -3.8 mio. | 9 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Clinical-Microbiomics A/S is 37230634.
The owners of Clinical-Microbiomics A/S include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF.
The management of Clinical-Microbiomics A/S consists of Anders Christian Neto de Sousa Grøn.
The board of Clinical-Microbiomics A/S consists of Manoj Nirmal Dadlani, Bruce Harvey Grant and Caroline Popper, with Manoj Nirmal Dadlani as chair.
In 2025, Clinical-Microbiomics A/S reported a gross profit of EUR 2,831,000.
Clinical-Microbiomics A/S had 18 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Clinical-Microbiomics A/S has published its annual report for 2025. Gross profit came to DKK 2,831,000, and the net result was DKK -2,586,000.
Clinical-Microbiomics A/S has published its annual report for 2024. Gross profit came to DKK 548,000, and the net result was DKK -4,328,000.
As of July 1, 2024, is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
As of July 1, 2024, is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
Clinical-Microbiomics A/S has published its annual report for 2023. Gross profit came to DKK 1,779,000, and the net result was DKK -1,951,000.
As of October 9, 2023, Morten Otto Alexander Sommer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Manoj Nirmal Dadlani has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Nathan Allen Ledeboer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Bruce Harvey Grant has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Rasmus Vendler Toft-Kehler has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Torben Thomasen has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Henrik Dalbøge has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Thomas Alsbjerg has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, MANJIN ApS is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
As of October 9, 2023, VENDLER ApS is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
As of October 9, 2023, is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 33%.
As of October 8, 2023, Morten Otto Alexander Sommer has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2022. Gross profit came to DKK 18,987,402, and the net result was DKK -6,908,831.
As of June 2, 2023, Caroline Popper has joined the board of directors of Clinical-Microbiomics A/S.
As of October 12, 2022, Torben Thomasen has joined the board of directors of Clinical-Microbiomics A/S.
As of July 1, 2022, Isabelle Valerie de Cremoux has joined the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2021. Gross profit came to DKK 16,768,941, and the net result was DKK -1,722,969.
As of October 1, 2021, Anders Christian Neto de Sousa Grøn is registered as adm. dir. of Clinical-Microbiomics A/S.
As of September 30, 2021, Martin Andreas Santini has stepped down as adm. dir. of Clinical-Microbiomics A/S.
As of June 28, 2021, Morten Asser Karsdal has left the board of directors of Clinical-Microbiomics A/S.
As of June 8, 2021, Ole Skov has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2020. Gross profit came to DKK 17,023,992, and the net result was DKK 816,247.
As of January 28, 2021, Ole Skov has joined the board of directors of Clinical-Microbiomics A/S.
As of January 28, 2021, Thomas Alsbjerg has joined the board of directors of Clinical-Microbiomics A/S.
As of January 28, 2021, Dennis Landbo Nielsen has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2019. Gross profit came to DKK 13,163,250, and the net result was DKK 106,977.
As of November 1, 2019, Morten Asser Karsdal has joined the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2018. Gross profit came to DKK 8,507,396, and the net result was DKK -482,947.
Clinical-Microbiomics A/S has published its annual report for 2017. Gross profit came to DKK 1,421,891, and the net result was DKK -4,377,471.
As of October 29, 2017, Morten Otto Alexander Sommer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 29, 2017, Ole Skov has left the board of directors of Clinical-Microbiomics A/S.
As of October 28, 2017, Morten Otto Alexander Sommer has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its interim report for the period November 2, 2015 – December 31, 2016.
As of August 24, 2016, Henrik Dalbøge has joined the board of directors of Clinical-Microbiomics A/S.
As of July 4, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Clinical-Microbiomics A/S.
As of July 4, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of Clinical-Microbiomics A/S.
As of June 1, 2016, Martin Andreas Santini is registered as adm. dir. of Clinical-Microbiomics A/S.
As of June 1, 2016, Lone Merete Veng has stepped down as adm. dir. of Clinical-Microbiomics A/S.
As of January 1, 2016, Lone Merete Veng is registered as adm. dir. of Clinical-Microbiomics A/S.
As of January 1, 2016, Rasmus Vendler Toft-Kehler has stepped down as director of Clinical-Microbiomics A/S.
As of January 1, 2016, Morten Otto Alexander Sommer has stepped down as director of Clinical-Microbiomics A/S.
As of December 16, 2015, Rasmus Vendler Toft-Kehler has joined the board of directors of Clinical-Microbiomics A/S.
As of December 16, 2015, Dennis Landbo Nielsen has joined the board of directors of Clinical-Microbiomics A/S.
As of December 16, 2015, Ole Skov has joined the board of directors of Clinical-Microbiomics A/S.
As of December 16, 2015, Morten Otto Alexander Sommer has joined the board of directors of Clinical-Microbiomics A/S.
As of November 2, 2015, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of Clinical-Microbiomics A/S.
As of November 2, 2015, Rasmus Vendler Toft-Kehler is registered as director of Clinical-Microbiomics A/S.
As of November 2, 2015, Morten Otto Alexander Sommer is registered as director of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S was founded on November 2, 2015.
Companies in the same industry and area
CVR 39330784
CVR 26333210
CVR 26392861
CVR 41366044
CVR 27701396
